Literature DB >> 31021491

Uptake into a bedside needle and syringe program for acute care inpatients who inject drugs.

Hannah L Brooks1,2, Daniel C O'Brien1,2, Ginetta Salvalaggio1,3, Kathryn Dong1,4, Elaine Hyshka1,2.   

Abstract

INTRODUCTION AND AIMS: Injection drug use is associated with significant morbidity and mortality worldwide. Needle and syringe programs (NSP) have been shown to reduce negative health outcomes for people who inject drugs. However, NSPs have limited reach in hospitals, and no peer-reviewed research has examined NSP implementation in acute care settings. We describe the implementation of an inpatient NSP offered through an addiction medicine consultation service in a large, urban acute care hospital in Edmonton, Canada, and compared characteristics of inpatients who did versus did not access the NSP. DESIGN AND METHODS: Administrative data were reviewed for all addiction medicine consult service intakes between 11 July 2016 and 14 January 2018. We calculated the proportion of intakes in which patients: (i) were offered syringes; and (ii) accepted syringes. Multivariate analyses were used to examine associations between these outcomes and patient age and sex.
RESULTS: Patients reported injecting drugs in 597 (31%) of 1907 intakes during the study period. People who inject drugs were offered syringes in 334 (56%) of these intakes, and accepted syringes in 124 (37%) of them. Female patients were more likely to accept syringes. DISCUSSION AND
CONCLUSIONS: In a recently implemented NSP for hospital inpatients, just over half of patients who reported injection drug use were offered syringes, and the rate of patient acceptance was low. Further research is necessary to describe best practice for inpatient NSPs and identify and remove any barriers that prevent some inpatients from either being offered or accepting syringes.
© 2019 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  harm reduction; hospital; inpatient; needle exchange program; substance use disorder

Year:  2019        PMID: 31021491     DOI: 10.1111/dar.12930

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  4 in total

Review 1.  Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: a Narrative Review.

Authors:  Simeon Kimmel; Paxton Bach; Alexander Y Walley
Journal:  J Gen Intern Med       Date:  2020-05-27       Impact factor: 5.128

2.  Unequal access to opioid agonist treatment and sterile injecting equipment among hospitalized patients with injection drug use-associated infective endocarditis.

Authors:  Thomas D Brothers; Kimiko Mosseler; Susan Kirkland; Patti Melanson; Lisa Barrett; Duncan Webster
Journal:  PLoS One       Date:  2022-01-26       Impact factor: 3.240

3.  The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder.

Authors:  Allison J Ober; Cristina Murray-Krezan; Kimberly Page; Peter D Friedmann; Karen Chan Osilla; Stephen Ryzewicz; Sergio Huerta; Mia W Mazer; Isabel Leamon; Gabrielle Messineo; Katherine E Watkins; Teryl Nuckols; Itai Danovitch
Journal:  Addict Sci Clin Pract       Date:  2022-07-28

4.  Principles of Harm Reduction for Young People Who Use Drugs.

Authors:  Simeon D Kimmel; Jessie M Gaeta; Scott E Hadland; Eliza Hallett; Brandon D L Marshall
Journal:  Pediatrics       Date:  2021-01       Impact factor: 7.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.